Table of contents
June 2002 Vol 2 No 6
In this issue
p399 | doi:10.1038/nrc831
Research Highlights
Tumorigenesis: Origins
p401 | doi:10.1038/nrc826
Epigenetics: Breaking the silence
p402 | doi:10.1038/nrc825
Therapeutics: Controlled destruction
p402 | doi:10.1038/nrc834
Ongogenesis: A life or death situation
p403 | doi:10.1038/nrc827
Tumour–stroma interactions:: The causes of crime
p404 | doi:10.1038/nrc829
Chemoprevention: Long-distance relationship
p404 | doi:10.1038/nrc830
P53 regulation: Hitting the G spot
p405 | doi:10.1038/nrc828
Web Watch
Microarray mania
p405 | doi:10.1038/nrc837
Drug resistance: Resisting arrest
p406 | doi:10.1038/nrc833
Trial Watch
Anti-angiogenics
p406 | doi:10.1038/nrc836
Genomic instability: Two worlds collide
p407 | doi:10.1038/nrc832
News in Brief
Therapeutics | Tumour suppressors | Oncogenes | Therapeutics
p407 | doi:10.1038/nrc835
Focus on: Stem Cells
Reviews
Gene therapy to protect haematopoietic cells from cytotoxic cancer drugs
Brian P. Sorrentino
p431 | doi:10.1038/nrc823
Reviews
Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses
Cassian Yee & Philip Greenberg
p409 | doi:10.1038/nrc820
Targeting death and decoy receptors of the tumour-necrosis factor superfamily
Avi Ashkenazi
p420 | doi:10.1038/nrc821
Epithelial–mesenchymal transitions in tumour progression
Jean Paul Thiery
p442 | doi:10.1038/nrc822
Mechanisms of smoking-related lung and pancreatic adenocarcinoma development
Hildegard M. Schuller
p455 | doi:10.1038/nrc824
Perspectives
Timeline
Fortuitous convergences: the beginnings of JUN
Peter K. Vogt
p465 | doi:10.1038/nrc818
Opinion
Histone methyltransferases, diet nutrients and tumour suppressors
Shi Huang
p469 | doi:10.1038/nrc819

